🔎 Trials Near Me

Hjem › Alvorlig depressiv lidelse › Washington › Everett

Alvorlig depressiv lidelse kliniske forsøg i Everett, WA

8 studier for Alvorlig depressiv lidelse søger deltagere på steder i og omkring Everett (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

RekruttererFase 3
  • Core Clinical Research, Everett
Alder 18 til 74 · Alle køn · Opdateret 25. sep. 2026 · NCT06559306

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

RekruttererFase 3
  • Core Clinical Research, Everett
Alder 18 til 85 · Alle køn · Opdateret 25. sep. 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

RekruttererFase 2
  • Seaport Investigator Site, Everett
Alder 18 til 65 · Alle køn · Opdateret 14. sep. 2026 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

RekruttererFase 3
  • Core Clinical Research, Everett
Alder 18 til 74 · Alle køn · Opdateret 3. aug. 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Everett
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

RekruttererFase 2
  • Core Clinical Research /ID# 277518, Everett
Alder 18 til 65 · Alle køn · Opdateret 15. jun. 2026 · NCT07276997

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Everett
Alder 18 og opefter · Alle køn · Opdateret 29. okt. 2025 · NCT06786624

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

RekruttererFase 4
  • Clinical Research Site, Everett
Alder 18 til 65 · Alle køn · Opdateret 23. jan. 2025 · NCT06223880

Alvorlig depressiv lidelse forsøg i andre byer

Andre studier i Everett

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.